KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS

A novel study describes the development and validation of a selective and simple kinetic spectrophotometric method for the determination of some analgesic drugs namely, morphine (MOF), nalbuphine (NAB) and naltrexone (NAT) in bulk and in pharmaceutical formulations. This method was based on the reac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: EL-DIDAMONY,AKRAM M, SAAD,MONIR Z, SALEEM,NORA O
Lenguaje:English
Publicado: Sociedad Chilena de Química 2013
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000300025
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072013000300025
record_format dspace
spelling oai:scielo:S0717-970720130003000252014-09-09KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONSEL-DIDAMONY,AKRAM MSAAD,MONIR ZSALEEM,NORA O Kinetic spectrophotometric potassium permanganate NaOH morphine nalbuphine naltrexone dosage forms A novel study describes the development and validation of a selective and simple kinetic spectrophotometric method for the determination of some analgesic drugs namely, morphine (MOF), nalbuphine (NAB) and naltrexone (NAT) in bulk and in pharmaceutical formulations. This method was based on the reaction of the drugs under studying with alkaline KMnO4 to form a water-soluble bluish green colored product with a maximum absorbance at 605 nm. Although, the determination of MOF, NAB and NAT drugs by rate constant, fixed-concentration and fixed time methods were feasible with the calibration equations obtained, the fixed time method has been found to be more applicable. The fixed-time method is adopted for constructing the calibration curves, which were found to be linear over the concentration ranges of 4 - 18 μg mL-1 MOF, 2 - 20 μg mL-1 NAB and 2 - 16 μg mL-1 NAT. Different experimental parameters which can affect the development and stability of the color were carefully studied and optimized. The fixed time method of 20 min was further applied to pharmaceutical formulations of each drug and the percentage recoveries were 99.85±0.049 to 102.27±0.024. Statistical comparisons of the results with the reference methods show the excellent agreement and indicate no significant difference in accuracy and precision.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.58 n.3 20132013-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000300025en10.4067/S0717-97072013000300025
institution Scielo Chile
collection Scielo Chile
language English
topic Kinetic spectrophotometric
potassium permanganate
NaOH
morphine
nalbuphine
naltrexone
dosage forms
spellingShingle Kinetic spectrophotometric
potassium permanganate
NaOH
morphine
nalbuphine
naltrexone
dosage forms
EL-DIDAMONY,AKRAM M
SAAD,MONIR Z
SALEEM,NORA O
KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
description A novel study describes the development and validation of a selective and simple kinetic spectrophotometric method for the determination of some analgesic drugs namely, morphine (MOF), nalbuphine (NAB) and naltrexone (NAT) in bulk and in pharmaceutical formulations. This method was based on the reaction of the drugs under studying with alkaline KMnO4 to form a water-soluble bluish green colored product with a maximum absorbance at 605 nm. Although, the determination of MOF, NAB and NAT drugs by rate constant, fixed-concentration and fixed time methods were feasible with the calibration equations obtained, the fixed time method has been found to be more applicable. The fixed-time method is adopted for constructing the calibration curves, which were found to be linear over the concentration ranges of 4 - 18 μg mL-1 MOF, 2 - 20 μg mL-1 NAB and 2 - 16 μg mL-1 NAT. Different experimental parameters which can affect the development and stability of the color were carefully studied and optimized. The fixed time method of 20 min was further applied to pharmaceutical formulations of each drug and the percentage recoveries were 99.85±0.049 to 102.27±0.024. Statistical comparisons of the results with the reference methods show the excellent agreement and indicate no significant difference in accuracy and precision.
author EL-DIDAMONY,AKRAM M
SAAD,MONIR Z
SALEEM,NORA O
author_facet EL-DIDAMONY,AKRAM M
SAAD,MONIR Z
SALEEM,NORA O
author_sort EL-DIDAMONY,AKRAM M
title KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
title_short KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
title_full KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
title_fullStr KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
title_full_unstemmed KINETIC SPECTROPHOTOMETRY METHOD FOR THE DETERMINATION OF MORPHINE, NALBUPHINE AND NALTREXONE DRUGS IN BULK AND PHARMACEUTICAL FORMULATIONS
title_sort kinetic spectrophotometry method for the determination of morphine, nalbuphine and naltrexone drugs in bulk and pharmaceutical formulations
publisher Sociedad Chilena de Química
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000300025
work_keys_str_mv AT eldidamonyakramm kineticspectrophotometrymethodforthedeterminationofmorphinenalbuphineandnaltrexonedrugsinbulkandpharmaceuticalformulations
AT saadmonirz kineticspectrophotometrymethodforthedeterminationofmorphinenalbuphineandnaltrexonedrugsinbulkandpharmaceuticalformulations
AT saleemnorao kineticspectrophotometrymethodforthedeterminationofmorphinenalbuphineandnaltrexonedrugsinbulkandpharmaceuticalformulations
_version_ 1718445495239573504